Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Jan 24;23(1):61.
doi: 10.1186/s12888-023-04552-y.

Effects of antipsychotic and anticholinergic medications on cognition in chronic patients with schizophrenia

Chadia Haddad  1   2   3   4   5   6 , Pascale Salameh  7   8   9   10 , Hala Sacre  7 , Jean-Pierre Clément  11   12   13 , Benjamin Calvet  11   12   13
Affiliations

Effects of antipsychotic and anticholinergic medications on cognition in chronic patients with schizophrenia

Chadia Haddad et al. BMC Psychiatry. .

Abstract

Background: Patients with psychosis frequently use a variety of psychotropic medicines, many of which have anticholinergic effects that can impair cognition. Therefore, this study aimed to evaluate whether there is an association between medications used for neuropsychological disorders/symptoms and cognition in patients with schizophrenia, focusing on their anticholinergic load and antipsychotic doses.

Study design: A cross-sectional study between July 2019 and Mars 2020 at the Psychiatric Hospital of the Cross-Lebanon enrolled 120 inpatients diagnosed with schizophrenia. The total anticholinergic burden was calculated based on the Anticholinergic Drug Scale (ADS), and the chlorpromazine equivalent dose was calculated using the Andreasen method to assess the relative antipsychotic dose. Also, the objective cognition was assessed using the Brief Assessment of Cognition in Schizophrenia (BACS) tool.

Study results: A significantly higher BACS total score (r = -0.33, p < 0.001), higher verbal memory (r = -0.26, p = 0.004), higher working memory (r = -0.20, p = 0.03), higher motor speed (r = -0.36, p < 0.001), and higher attention and speed of information processing (r = -0.27, p = 0.003) were significantly associated with lower chlorpromazine equivalent dose. Higher ADS (Standardized Beta (SB) = -.22; p = .028), higher chlorpromazine equivalent dose (SB = -.30; p = .001), and taking mood stabilizer medications (SB = -.24; p = .004) were significantly associated with lower cognition.

Conclusion: This study confirms that the cognitive functions of chronic patients with schizophrenia may be affected by medications and their anticholinergic burden. More studies are needed to explain the role of cholinergic neurotransmission and general neurochemical mechanisms in the cognitive impairment of patients with schizophrenia.

Keywords: Anticholinergic activity; Antipsychotics; Cognition; Schizophrenia.

PubMed Disclaimer

Conflict of interest statement

The authors have nothing to disclose.

Figures

Fig. 1
Fig. 1
Association between the categories of Anticholinergic drug scale (ADS) and cognitive domains
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Heinrichs RW, Zakzanis KK. Neurocognitive deficit in schizophrenia: a quantitative review of the evidence. Neuropsychology. 1998;12(3):426. doi: 10.1037/0894-4105.12.3.426. - DOI - PubMed
    1. Keefe RS, Eesley CE, Poe MP. Defining a cognitive function decrement in schizophrenia. Biol Psychiat. 2005;57(6):688–691. doi: 10.1016/j.biopsych.2005.01.003. - DOI - PubMed
    1. Bora E, Murray RM. Meta-analysis of cognitive deficits in ultra-high risk to psychosis and first-episode psychosis: do the cognitive deficits progress over, or after, the onset of psychosis? Schizophr Bull. 2014;40(4):744–755. doi: 10.1093/schbul/sbt085. - DOI - PMC - PubMed
    1. Rajji TK, Miranda D, Mulsant BH. Cognition, function, and disability in patients with schizophrenia: a review of longitudinal studies. The Canadian Journal of Psychiatry. 2014;59(1):13–17. doi: 10.1177/070674371405900104. - DOI - PMC - PubMed
    1. Dickinson D, Ragland JD, Gold JM, Gur RC. General and specific cognitive deficits in schizophrenia: Goliath defeats David? Biol Psychiat. 2008;64(9):823–827. doi: 10.1016/j.biopsych.2008.04.005. - DOI - PMC - PubMed

Publication types